Back to Search
Start Over
Systematic development of a highly efficient cell factory for 5-aminolevulinic acid production.
- Source :
-
Trends in biotechnology [Trends Biotechnol] 2024 Aug 06. Date of Electronic Publication: 2024 Aug 06. - Publication Year :
- 2024
- Publisher :
- Ahead of Print
-
Abstract
- The versatile applications of 5-aminolevulinic acid (5-ALA) across the fields of agriculture, livestock, and medicine necessitate a cost-efficient biomanufacturing process. In this study, we achieved the economic viability of biomanufacturing this compound through a systematic engineering framework. First, we obtained a 5-ALA synthase (ALAS) with superior performance by exploring its natural diversity with divergent evolution. Subsequently, using a genome-scale model, we identified and modified four key targets from distinct pathways in Escherichia coli, resulting in a final enhancement of 5-ALA titers up to 21.82 g/l in a 5-l bioreactor. Furthermore, recognizing that an imbalance of redox equivalents hindered further titer improvement, we developed a dynamic control system that effectively balances redox status and carbon flux. Ultimately, we collaboratively optimized the artificial redox homeostasis system at the transcription level with other cofactors at the feeding level, demonstrating the highest recorded performance to date with a titer of 63.39 g/l for the biomanufacturing of 5-ALA.<br />Competing Interests: Declaration of interests The authors have filed a provisional patent for this work to the China National Intellectual Property Administration (CNIPA). The patent application numbers are 202410584439.7 and 202410584441.4.<br /> (Copyright © 2024 Elsevier Ltd. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1879-3096
- Database :
- MEDLINE
- Journal :
- Trends in biotechnology
- Publication Type :
- Academic Journal
- Accession number :
- 39112275
- Full Text :
- https://doi.org/10.1016/j.tibtech.2024.06.004